Harrill Alison Hege, Rusyn Ivan
University of North Carolina at Chapel Hill, 0031 Michael Hooker Research Center, Curriculum in Toxicology, CB 7431, Chapel Hill, NC, 27599, USA.
Expert Opin Drug Metab Toxicol. 2008 Nov;4(11):1379-89. doi: 10.1517/17425255.4.11.1379.
Extensive growth in the field of molecular biology in recent decades has led to the development of new and powerful experimental and computational tools that enable the analysis of complex biological responses to chemical exposure on both a functional and structural genetic level. The ability to profile global responses on a transcriptional level has become a valuable resource in the science of toxicology and attempts are now being made to further understand toxicity mechanisms by incorporating metabolomics and proteomics approaches. In addition, recent progress in understanding the extent of the genetic diversity within and between species allows us to take a fresh look at research on genetic polymorphisms that may influence an individual's susceptibility to toxicity. Whereas new technologies have the potential to make a sizeable impact on our understanding of the mechanisms of toxicity, considerable challenges remain to be addressed, especially with regard to the regulatory acceptance and successful integration of omics data. This review highlights recent advancements in the application of functional and structural genomics techniques to chemical hazard identification and characterization, and to the understanding of the interindividual differences in susceptibility to adverse drug reactions.
近几十年来,分子生物学领域的广泛发展催生了新的强大实验和计算工具,这些工具能够在功能和结构基因层面分析化学物质暴露引发的复杂生物反应。在转录水平上剖析全局反应的能力已成为毒理学领域的一项宝贵资源,目前人们正尝试通过整合代谢组学和蛋白质组学方法来进一步理解毒性机制。此外,在了解物种内部和物种之间遗传多样性程度方面取得的最新进展,使我们能够重新审视关于可能影响个体毒性易感性的基因多态性研究。尽管新技术有可能对我们理解毒性机制产生重大影响,但仍有诸多挑战有待解决,尤其是在组学数据的监管接受度和成功整合方面。本综述重点介绍了功能和结构基因组学技术在化学危害识别与表征以及理解个体间药物不良反应易感性差异方面的最新进展。